Skip to content

" accesskey="S">

Skip to content

2016 INTERNATIONAL SYMPOSIUM ON NANOBIOTECHNOLOGY

NanoMedicine from discovery to clinical reality: therapeutics, delivery and imaging

Preliminary Agenda / Subject to change

Wednesday, February 3rd

4:00 – 6:00 pm Opening Reception, Check-In, and Optional CNSI Core Laboratory Tours

Thursday, February 4th

7:30 – 8:40 am Breakfast and Check-In
8:40 – 9:00 am Welcome and Introduction
Ann Karagozian, PhD, - Interim Vice Chancellor for Research, UCLA
Jeff F. Miller, PhD - Director, UCLA California NanoSystems Institute
Heather Maynard, PhD - Associate Director, UCLA California NanoSystems Institute

Session 1
Moderated by: Heather Maynard

9:00 – 9:40 am Kazunori Kataoka, PhD – Professor, Materials Engineering, Graduate School of Engineering; Division of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo; Director General, Innovative Center of NanoMedicine (iCONM)

"Smart Targeted Therapy of Intractable Diseases"

9:40 – 10:05 am Mihail C. Roco, PhD – Senior Advisor for Science and Engineering, National Science Foundation; and National Nanotechnology Initiative

"Nanobiotechnology in a Convergence Spiral"

10:05 – 10:45 am David J. Mooney, PhD – Robert P. Pinkas Family Professor of Bioengineering, John A. Paulson School of Engineering and Applied Sciences, Harvard University

"Material Based Therapeutic Cancer Vaccines"

10:45 – 11:00 am Break
11:00 – 11:25 am Steve Dubinett, MD – Professor of Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology; Chief, Div. Pulmonary and Critical Care Medicine; Director, Clinical and Translational Science Institute, UCLA; Sr. Assoc. Dean for Translational Research, UCLA; Associate Vice Chancellor for Research, UCLA
&
Leonard Rome, PhD – Professor, Biological Chemistry; Associate Director, California NanoSystems Institute, UCLA; Scientific Founder and Chief Scientific Officer, VaultNano Inc.

"Chemokine-Mediated Immunotherapy for Cancer"

11:25 – 11:50 am Andre Nel, MB ChB, PhD – Distinguished Professor and Chief of NanoMedicine, Department of Medicine; Associate Director, California NanoSystems Institute; Director of the Center for Environmental Implications of Nanotechnology; Associate Editor, ACS Nano

"An Engineered Approach to Therapeutics and Immune Perturbation for Pancreatic Cancer"

11:50 am – 12:15 pm Chunying Chen, PhD – Professor, National Center for Nanoscience and Technology, Chinese Academy of Sciences

"Near-infrared Light-Mediated Nanomaterials as Precision Nanomedicine"

12:15 – 1:15 pm Lunch

Session 2
Moderated by: Andre Nel

1:15 – 1:55 pm Molly Stevens FREng, PhD – Professor, Biomedical Materials and Regenerative Medicine; Research Director, Biomedical Material Sciences, Department of Materials, Department of Bioengineering and the Institute of Biomedical Engineering, Imperial College

"Designing Nanomaterials for Regenerative Medicine and Biosensing"

1:55 – 2:20 pm Anna Wu, PhD – Director, JCCC Cancer Molecular Imaging; Professor, Molecular & Medical Pharmacology; Faculty, Cellular and Molecular Pathology PhD Program, Crump Institute for Molecular Imaging, UCLA

"Engineered Antibodies for In Vivo Targeting and Imaging"

2:20 – 3:00 pm Paula T. Hammond, PhD – David H. Koch Professor and Department Head, Department of Chemical Engineering; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

"Nanolayered Thin Film Delivery Systems for Biomedical Device Application"

3:00 – 3:20 pm Break
3:20 – 3:45 pm Jeroen Cornelissen, PhD – Scientific Director, MESA+ Institute; Professor, Biomolecular Nanotechnology, University of Twente

"Virus Capsid-Based Nanocontainers as Multimodal Delivery Vehicles"

3:45 – 4:10 pm Julia Liubimova, MD, PhD – Director, Nanomedicine Research Center, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai

"Nanobioconjugates for Glial Tumors Imaging and Treatment. Inhibition of Laminin-Integrin-Notch Pathway"

4:10 – 4:35 pm Agneta Richter-Dahlfors, PhD – Professor, Center Director, Swedish Medical Nanoscience Center, Karolinska Institute

"Pathophysiology of Bacterial Infection Deciphered by Intravital Imaging, Biosensors and Biomimetic Devices"

Nanotechnology-Inspired Grand Challenges: Microbiome
Moderated by: Jeff F. Miller

4:35 – 4:50 pm Jeff F. Miller, PhD – Director, California NanoSystems Institute; Fred Kavli Chair, NanoSystems Sciences; Professor, Microbiology,Immunology & Molecular Genetics, UCLA

"The Unified Microbiome Initiative: a Call for Transformative Tools"

4:50 – 5:15 pm Pieter Dorrestein, PhD – Director, Collaborative Mass Spectrometry Innovation Center; Co-Director, Institute for Metabolomics Medicine, Skaggs School of Pharmacy & Pharmaceutical Sciences, USCD

"3D Cartography of Microbiome Chemistry"

5:15 – 5:40 pm Elaine Y. Hsiao, PhD – Assistant Professor, Integrative Biology and Physiology, UCLA

"Toward Understanding Mechanisms for Microbiome-Nervous System Interactions"

5:40 – 7:00 pm Reception and Poster Session

Friday, February 5th

7:30 – 8:20 am Breakfast

Session 3
Moderated by: Hsian Rong Tseng

8:20 – 8:50 am Paul S. Weiss, PhD – Distinguished Professor, Chemistry and Biochemistry, Materials Science and Engineering, UCLA; UC Presidential Chair; Editor-in-Chief, ACS Nano

"Nanoscience Approaches to Heterogeneity in Biological Systems"

8:50 – 9:20 am Chen Wang, PhD – Professor, National Center for Nanoscience and Technology; Deputy Director, Interface and Surface Physics Committee of Chinese Physics Society; Director, Youth Lab of Nanotech, Chinese Academy of Sciences

"Structural Analysis of Amyloidal Peptides by Using STM"

9:20 – 9:50 am Kostas Kostarelos, PhD – Chair of Nanomedicine, Faculty of Medical and Human Sciences & the National Graphene Institute, University of Manchester

"Pharmacology and Toxicology of 1D and 2D Carbon Nanostructures"

9:50 – 10:15 am Break
10:15 – 10:40 am Esther Chang, PhD – Professor, Oncology and Otolaryngology, Lombardi Comprehensive Cancer Center, Georgetown University; Founder and Senior Consultant SynerGene Therapeutics Inc.; President, The American Society for NanoMedicine

"Clinical Studies on Systemic Delivery of Cancer Nanomedicines for Metastatic Disease"

10:40 – 11:05 am Christian Plank, PhD – Professor, Institute of Experimental Oncology and Therapy Research, Technische Universitδt Mόnchen; CSO & President, Ethris GmbH

"Nucleic Acid Delivery - From Academic Discovery to Drug Development"

11:05 am – 12:05 pm Translation and Commercialization Panel Discussion

Moderator: Leonard Rome – Professor, Biological Chemistry; Associate Director, California NanoSystems Institute, UCLA; Scientific Founder and Chief Scientific Officer, VaultNano Inc.

Participants:
  • Piotr Grodzinski, PhD – Director, National Cancer Institute, Office of Cancer Nanotechnology Research, NIH

  • Iulian Bobe, MD – Director, International Business Development, Research Division, Nanocarrier Co., Ltd

  • Anil K. Patri, PhD – NCTR-ORA Nanotechnology Core Facility, Office of Scientific Coordination, National Center for Toxicological Research (NCTR), FDA

  • Michael Silton – Executive Director, UCLA Venture Capital Fund
12:05 – 1:30 pm Lunch

Session 4
Moderated by: Fuyuhiko Tamanoi

1:30 – 1:55 pm Andrea Kasko, PhD – Associate Professor, Bioengineering, UCLA
&
Gerard Wong, PhD – Professor, Bioengineering, Chemistry & Biochemistry, UCLA

"Pentobra: A Novel Multifunctional Antibiotic to Fight Bacterial Resistance

1:55 – 2:20 pm Adah Almutairi, PhD – Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD; Co-Director, Center of Excellence in Nanomedicine & Engineering

"Smart Automated Drug Release; Because Drugs Don't Work in Patients Who Don't Take Them"

2:20 – 2:45 pm Jeffrey I. Zink, PhD – Distinguished Professor of Chemistry, UCLA

"Multifunctional Mesoporous Silica Nanoparticles Controlled by Nanomachines for Biomedical Targeting, Imaging and Drug Delivery"

2:45 – 3:10 pm Jacob Berlin, PhD – Assistant Professor, Molecular Medicine, Beckman Research Institute, City of Hope

"Nanoparticle/Stem Cell Hybrids for Targeted Cancer Therapy"

3:10 – 3:30 pm Break

Adjacent Sessions

Adjacent Session 1 Nanobiotechnology Tools
Moderated by: Adam Stieg | Location: Presentation Space

3:30 – 3:50 pm Tae-Young Yoon, PhD – Professor, Center for Nanomedicine, Institute for Basic Science (IBS) and Y-IBS Institute, Yonsei University

"Personalized Medicine Guided by Single-Molecule Imaging"

3:50 – 4:05 pm Susan Lφffler, PhD – Swedish Medical Nanoscience Center, Department of Neuroscience, Karolinska Institute

"Simultaneous Optical and Electronic Monitoring of the Dynamics of Cellular Barrier Integrity in Health and Disease"

4:05 – 4:20 pm Ji-Wook Kim – Graduate Student, Center for Evolutionary Nanoparticles (CEN), Department of Chemistry, Yonsei University

"Ultrafast Mechanical Control of Inner Ear Hair Cells Using Magnetic Nanoparticles"

4:20 – 4:35 pm Shingo Ueno, PhD – Deputy Principal Research Scientist, Innovation Center of NanoMedicine (iCONM Ichiki Lab)

"Development of Functional Biomolecules by Artificial Selection Using Cell-Free System and Microarray Technology"

Adjacent Session 2 Nanomedicine
Moderated by: Dino Dicarlo | Location: CNSI Auditorium



3:30 – 3:50 pm Hiroaki Kinoh, PhD – Deputy Principal Research Scientist, Innovation Center of NanoMedicine (iCONM Kataoka Lab)

"Nanomedicines Eradicating Cancer Stem Cells In Vivo by pH-Triggered Cooperative Action of Loaded Drugs"

3:50 – 4:05 pm Ethan White - Graduate Student, Beckman Research Institute, City of Hope

"A Carbon Nanotube-Based Immunotherapeutic Both Enhances Immune Stimulation and Inhibits Tumor Migration"

4:05 – 4:20 pm Sabina Quadar, PhD - Senior Research Scientist, Innovation Center of NanoMedicine (iCONM Kataoka Lab)

"Targeted Brain Tumor Therapy by Epirubicin-Loaded Polymeric Micelles Augmented by cRGD Peptide"

4:20 – 4:35 pm Fawzia Bardag-Gorce, PhD - Associate Researcher, Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA; LA BioMed

"Oral Mucosa Epithelial Cell Sheet Ubiquitin Proteasome Pathway Analysis"

4:40 – 4:50 pm Summary of Adjacent Session by Moderators
4:50 – 5:00 pm Closing Remarks, End of Symposium
Heather Maynard, PhD - Associate Director, UCLA California NanoSystems Institute